Meet Our Customers
Join our customers on the road to faster innovation
18 of the world’s top 20 pharma companies use IDBS
Reduction in errors in regulated or compliant environments
Additional productivity increase per user
Improvement in speed of decision making
“We are rapidly reducing data handling time for a growing number of routine assays allowing our scientists to spend a higher portion of their time in the laboratory.”
Phil Bland-Ward, Chief Scientific Officer
Join our customers on the road to faster innovation
Serán is a leading contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies.
Apellis is committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system.
Freeline is a clinical-stage biotechnology company developing transformative gene therapies for patients suffering from inherited systemic debilitating diseases.
Angelini Pharma is the pharmaceutical division of Angelini Group. The Group started almost 100 years ago as a small pharmaceutical laboratory, and over the years has grown into a leading international group in healthcare, present in Pharmaceuticals and Mass-Market.
KBI Biopharma is an award-winning bipharmaceutical contract services organizations providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.
Seqirus has public health protection at its core. As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies and the latest methods of production and distribution.
Kriya is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy.
Matrivax is a clinical-stage biotechnology company developing human vaccines for the prevention and treatment of life-threatening infectious diseases.
USV is a 58 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, is a subsidiary of Revlon. USV product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables.
SEKISUI XenoTech is a specialty global Contract Research Organization (CRO) specializing in ADME/DMPK/DDI testing of potential drug candidates.
Goldfinch Bio is a cutting edge, fast-growing biotechnology company that is singularly focused on discovering and developing precision therapies for kidney disease.
Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) bacteria to be used in conjunction with commonly used antibiotics or as stand-alone medications.
Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing.
Celyad Oncology is a clinical-stage biotech company focused on the discovery and development of chimeric antigen receptor T-cell (CAR-T) therapies for cancer.
ROHTO Pharmaceutical Co., Ltd is a multinational company with a history of over 120 years, renowned for its fast-moving consumer goods and OTC drugs.
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food.
PharmaLegacy Laboratories is an AAALAC accredited Preclinical CRO providing specialty pharmacology services in Auto-Immune Diseases, Inflammation, Oncology, Bone Metabolism, Orthopedics, Liver/lung Diseases and Metabolic diseases.
iOmx Therapeutics focuses on the development of next-generation, first-in-class cancer immune-checkpoint inhibitors.
Koura is a global leader in the development, manufacture and supply of fluoroproducts, advancing life around the world.
Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables.
Nirogy Therapeutics is a biotechnology company based in Boston, MA developing novel small molecules to target cellular transporters.
Monogram Biosciences, Inc., is a leader in developing and commercializing innovative diagnostic products to help guide and improve the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases.
Godrej Agrovet Limited is an Indian company which operates in the animal feed and agribusiness sectors.
Helping to cure disease and protect everyday health. Otsuka Pharmaceutical is a holistic healthcare company dedicated to the entire body.
LIfT Biosciences is a biotech bringing to market a first-in-class ‘off-the-shelf’ innate cell therapy called Neutrophil based Leukocyte Infusion Therapy (N-LIfT).
Samsung Bioepis is a biopharmaceutical company dedicated to unlocking the potential of biosimilar medicines and transforming the way biologic therapies are brought to patients.
NaniteBio is a startup firm based in Boston, MA and specializing in chemical engineering.
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases.
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts.
Genective is a joint venture between Limagrain and KWS. Genective globally develops and provides innovative biotech solutions in corn.
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
IL develops and manufactures Hemostasis, Critical Care and Patient Blood Management (PBM) products. Key Accriva product additions to the Company’s portfolio include Hemochron, the gold standard for Activated Clotting Time (ACT) testing, and VerifyNow, the leading system for platelet function analysis, among other leading brands.
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness.
Arxada is a global specialty chemicals business with leading positions in Microbial Control Solutions (MCS) and Specialty Products Solutions (SPS).
Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Cerevel Therapeutics is working relentlessly to find paths through complexity in an effort to bring real progress and new treatment options to people living with a broad range of neuroscience diseases.
Swiss BioQuant is a bioanalytical contract research organization (CRO) specialized in LC-MS/MS and ligand-binding assays and dedicated to scientific excellence.
Dragonfly’s mission is to revolutionize cancer treatment by inventing therapies that harness the body’s immune system for vastly improved patient outcomes.
Book a demonstration